MARKKU TASKINEN

Laboratorioinsinööri

Yhteystiedot

Organisaatio

Terveystieteiden tiedekunta, Farmasian laitos

Sähköposti

markku.taskinen@uef.fi

Puhelin

040 355 2475

Julkaisut

Taskinen Markku, Hänninen Pirjo, Jaatinen Hannele, Rissanen Helly, Pitkänen Kaarina, Roivainen Anne, Ukkonen Sari, Pirskanen Lea. 2013. Teknisen työn kehitys ja muutokset farmasialla: Ahonen R, Laitinen K, Lapinjoki S, Mensalo P, Ranta V-P, Ylikangas H (toim)., Muutosten vuosikymmen : Itä-Suomen yliopiston farmasian laitos 40 vuotta. Publications of the University of Eastern Finland. General Series 13. 59-62. 2013
Räikkönen Johanna, Taskinen Markku, Dunford James E, Mönkkönen Hannu, Auriola Seppo, Mönkkönen Jukka. 2011. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 407: 663-667. 2011
Pajula K, Taskinen M, Lehto V-P, Ketolainen J & Korhonen O. 2010. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Molecular Pharmaceutics 7 3: 795-804. 2010
Töyräs A, Ollikainen J, Taskinen M, Mönkkönen J. 2003. Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 19: 223-230. 2003
Suri S, Mönkkönen J, Taskinen M, Pesonen J, Blank MA, Phipps RJ, Rogers MJ. 2001. Nitrogen-containing bisphosphonates induce apoptosis of caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity. BONE 29 4: 336-343. 2001
Mönkkönen J, Liukkonen J, Taskinen M, Heath TD, Urtti A. 1995. Studies on liposome formulations for intra-articular delivery of clodronate JOURNAL OF CONTROLLED RELEASE 35: 145-154. 1995
Mönkkönen J, Taskinen M, Auriola S, Urtti A. 1994. The growth inhibition of macrophage like and other cell types by liposome-encapsulated, calcium bound, and free bishosphonates in vitro JOURNAL OF DRUG TARGETING 2: 299-308. 1994